Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01454
|
|||||
| Drug Name |
Protoporphyrin
|
|||||
| Synonyms |
protoporphyrin IX; protoporphyrin; 553-12-8; Ooporphyrin; Protoporpyrin IX; Porphyrinogen IX; Protoporphyrin IX disodium; Kammerer's prophyrin; ppIX; Protoporphyrin IX (VAN); H2ppIX; Kammerer's porphyrin; MLS001074731; UNII-C2K325S808; NSC2632; NSC 2632; EINECS 209-033-7; 3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid; SMR000127405; 21H,23H-Porphine-2,18-dipropanoic acid, 7,12-diethenyl-3,8,13,17-tetramethyl-; CHEMBL267548; CHEBI:15430; C34H34N4O4
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Iron deficiency [ICD11: 5B5K.0] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C34H34N4O4
|
|||||
| Canonical SMILES |
CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C=C
|
|||||
| InChI |
InChI=1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16,35-36H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42)
|
|||||
| InChIKey |
ZCFFYALKHPIRKJ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 15415-30-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 562.7 | Topological Polar Surface Area | 132 | ||
| Heavy Atom Count | 42 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
4.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
5261
, 69254
, 596306
, 841432
, 4413024
, 4903491
, 7640482
, 7890005
, 8137800
, 8143177
, 8149710
, 10526884
, 11111672
, 11335249
, 11360488
, 11364194
, 11366756
, 11369318
, 11372499
, 11373857
, 11377480
, 11461460
, 11484907
, 11488832
, 11491255
, 11492234
, 11495114
, 11537733
, 14788515
, 14837581
, 17405531
, 24278655
, 26612168
, 26681019
, 26747639
, 26747640
, 26750425
, 29224047
, 32963314
, 32964437
, 46171309
, 46506247
, 47193689
, 47217031
, 47365444
, 47811014
, 48035384
, 49748473
, 50070313
, 50071311
|
|||||
| ChEBI ID |
ChEBI:15430
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03071497) Non-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IX | |||||
| 2 | Pharmacogenomic importance of ABCG2. Pharmacogenomics. 2008 Aug;9(8):1005-9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.